Differences Between Randomized Clinical Trial Patients and Real-World Initiators of the Glucagon-Like Peptide 1 Receptor Agonist Liraglutide

Research output: Contribution to journalLetterResearchpeer-review

DOI

  • Jakob Schöllhammer Knudsen
  • Reimar Wernich Thomsen
  • Anton Pottegård
  • Filip Krag Knop
  • Henrik Toft Sørensen

View graph of relations

LanguageEnglish
JournalDiabetes Care
Volume41
Issue number9
Pages (from-to)e133-e135
ISSN1733-5671
DOIs
StatePublished - 2018